2024-03-14 13:30:17 ET
Image source: The Motley Fool.
Agenus (NASDAQ: AGEN)
Q4 2023 Earnings Call
Mar 14, 2024 , 8:30 a.m. ET
Operator
For further details see:
Agenus (AGEN) Q4 2023 Earnings Call Transcript2024-03-14 13:30:17 ET
Image source: The Motley Fool.
Agenus (NASDAQ: AGEN)
Q4 2023 Earnings Call
Mar 14, 2024 , 8:30 a.m. ET
Operator
For further details see:
Agenus (AGEN) Q4 2023 Earnings Call TranscriptMarket Wire News is a media platform, the information on this page was provided by Motley Fool via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
2024-04-28 08:30:00 ET Last Friday, Agenus (NASDAQ: AGEN) , an immuno-oncology player, saw its shares soar by a staggering 40.8%. This remarkable rally occurred seemingly without a clear catalyst. The company is set to announce its first-quarter earnings for 2024 before the market o...
A look at the top 10 most actives in the United States Pineapple Energy Inc. (PEGY) rose 20.6% to $0.0626 on volume of 316,091,551 shares Snap Inc. Class A (SNAP) rose 27.6% to $14.55 on volume of 158,621,648 shares PROSHARES TRUST (SQQQ) fell 4.8% to $11.43 on volume of 135,432,504 share...
Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers, today announced an upcoming presentation from the Phase 1b trial of botensilimab in combination with balstilimab (“BOT/BAL”) in patients with relapsed/ref...